Quantity

Biocept to Present Data at RAS-Targeted Drug Development Summit Showing Ability of Its Switch-BlockerTM Technology to Detect Rare Cancer Mutations

Retrieved on: 
Tuesday, September 21, 2021
Oncology, Medical Devices, Health, Other Health, General Health, Biotechnology, Blood, EDT, Quantity, Cerebrospinal fluid, Cancer, NGS, Neoplasm, Clinical trial, Internet, Review, Diagnosis, NCCN, Ras GTPase, Risk, Solution, Security (finance), Therapy, Target, Private Securities Litigation Reform Act, DNA, U.S. Securities and Exchange Commission, Medical director, Patient, RAS, Physician, LinkedIn, Central nervous system, QNS, Twitter, COVID-19 testing, Public health, CEO, Terminology, COVID-19, Technology, Summit, Forward-looking statement, KRAS, Liquid biopsy, SEC, Lung, Medical imaging, Pharmaceutical industry

The Summit brings together academic and biopharmaceutical leaders to share insights and data to advance the successful development of targeted monotherapies and combination strategies for RAS-driven cancers.

Key Points: 
  • The Summit brings together academic and biopharmaceutical leaders to share insights and data to advance the successful development of targeted monotherapies and combination strategies for RAS-driven cancers.
  • In particular, KRAS mutations are present in approximately 25% of tumors, making them one of the most common gene mutations linked to cancer.
  • To support these efforts, Biocept offers flexible molecular testing solutions based on advanced technology, including its proprietary Switch-Blocker technology.
  • The companys Target Selector assays and kits, combined with its Switch-Blocker technology, enables the development of superior assays to detect and characterize genetic alterations in patients with cancer.

Cayuga Hospitality Consultants Adds to its International Consulting Network

Retrieved on: 
Monday, September 20, 2021
Goal, Quantity, RICS, Insurance, Review, InterContinental, Season, LinkedIn, University of Central Lancashire, Royal Institution of Chartered Surveyors, Royal Institution, Marketing, Consultant, University, Knowledge, Technology, Intel RealSense, Central Lancashire, Four Seasons Hotels and Resorts, Industry, Medicine, Hotel

SARASOTA, Fla., Sept. 14, 2021 /PRNewswire-PRWeb/ -- Cayuga Hospitality Consultants is excited to announce that Olivier Gauthier, based in Paris, France, has joined their team of global consultants.

Key Points: 
  • SARASOTA, Fla., Sept. 14, 2021 /PRNewswire-PRWeb/ -- Cayuga Hospitality Consultants is excited to announce that Olivier Gauthier, based in Paris, France, has joined their team of global consultants.
  • The addition of his expertise will provide international clients specialized services relating to their markets and countries and provide extensive knowledge about international hospitality trends.
  • Olivier joins the global team that includes:
    To learn more about the global team of consultants, visit Cayuga Hospitality Consultants.
  • Cayuga Hospitality Consultants is a global network of independent consultants focused on the hospitality industry.

Showa Denko Announces the Issue Price, Selling Price, and Matters Relating to its New Shares

Retrieved on: 
Monday, September 6, 2021
Economy of Japan, Financial markets, Companies, Fuyo Group, Showa Denko, Stock market, Corporate finance, Japanese yen, Stock

(the "Company") hereby announces the issue price, selling price and certain other matters relating to the issuance of its new shares and the secondary offering of shares which its board of directors resolved on August 23, 2021, as set forth below.

Key Points: 
  • (the "Company") hereby announces the issue price, selling price and certain other matters relating to the issuance of its new shares and the secondary offering of shares which its board of directors resolved on August 23, 2021, as set forth below.
  • in chemicals segment and 5,800,000,000 yen as investment funds for manufacturing facilities for SiC power semiconductor-related materials and lithium-ion battery materials, etc.
  • For more information regarding the use of proceeds, please refer to the press release "Announcement Regarding Issuance of New Shares and Secondary Offering of Shares" dated August 23, 2021.
  • Showa Denko K.K., CSR & Corporate Communication Office, Tel: 81-3-5470-3235

NASA Awards Contract for X-59 Community Overflight Operations

Retrieved on: 
Thursday, December 17, 2020
Articles, Academic disciplines, Philosophy, Lockheed Martin X-59 QueSST, NASA, Downtime, Armstrong Flight Research Center, Quantity

The contract is awarded through the agency's Armstrong Flight Research Center in Edwards, California.

Key Points: 
  • The contract is awarded through the agency's Armstrong Flight Research Center in Edwards, California.
  • The indefinite-delivery/indefinite-quantity price contract has a total value of $40 million and a performance period that runs through Dec. 14, 2025.
  • The contract will provide extra structural components and subsystems for the X-59 aircraft as a risk-reduction strategy to minimize downtime for the airplane during high-tempo operations.
  • In 2024, NASA will fly the X-59 over select communities to measure public perception of the sound.

VirTra Awarded $1.9 Million Contract to Support the Air Force Research Laboratory

Retrieved on: 
Monday, August 31, 2020
Government procurement in the United States, General Services Administration, IDIQ, Articles, Quantity, Government

(NASDAQ:VTSI) (VirTra), a global provider of training simulators for the law enforcement, military, educational and commercial markets, has been awarded a $1.9 million indefinite delivery/indefinite quantity (IDIQ) contract as a result of the Companys recent partnership with Infoscitex (IST), a subsidiary of DCS Corporation, in support of the Air Force Research Laboratorys Airman Decision Making and Interface Research (ADMIRE) program.

Key Points: 
  • (NASDAQ:VTSI) (VirTra), a global provider of training simulators for the law enforcement, military, educational and commercial markets, has been awarded a $1.9 million indefinite delivery/indefinite quantity (IDIQ) contract as a result of the Companys recent partnership with Infoscitex (IST), a subsidiary of DCS Corporation, in support of the Air Force Research Laboratorys Airman Decision Making and Interface Research (ADMIRE) program.
  • Under the terms of the agreement, VirTra will serve as a subcontractor to IST, which recently secured a portion of the 6-year ADMIRE contract, valued at $135 million.
  • The intent of the contract is to develop technology that improves US military warfighters decision-making and marksmanship skills.
  • VirTras work on this task order has already begun and VirTras involvement on the contract is expected to run through June 30, 2022.

Introducing the Reell TI-160 Molded Nylon Torque Insert with 'One-way' Torque

Retrieved on: 
Friday, December 14, 2018
Rotation, Physics, Force, Torque, Quantity, Wrenches, Torque wrench

The TI-160 is the first molded torque insert to feature Reell's 'One-way' torque technology which eliminates nearly all the torque required to move the hinge in one direction, without compromising the holding force in the other.

Key Points: 
  • The TI-160 is the first molded torque insert to feature Reell's 'One-way' torque technology which eliminates nearly all the torque required to move the hinge in one direction, without compromising the holding force in the other.
  • It is available torques range from 4.0 to 6.0 N-m, configured for high torque in either the forward or reverse direction.
  • It provides Reell's premium 'One-way' torque performance in a lightweight nylon molded torque insert that nicely compliments out existing product line.
  • Reell Precision Manufacturing provides high-quality innovative solutions to transmit torque, control angular position and protect delicate components from excessive force.